Bluejay Diagnostics, Inc.
BJDX
$1.94
$0.2414.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.37% | 40.13% | -6.31% | -1.12% | -0.20% |
| Total Depreciation and Amortization | -30.04% | -0.19% | -1.10% | -3.55% | -79.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -360.60% | -69.45% | 5,049.18% | 185.31% | 66.35% |
| Change in Net Operating Assets | 122.43% | -1,056.24% | -76.25% | 93.40% | -154.71% |
| Cash from Operations | 9.98% | -4.20% | 19.27% | 17.33% | -146.87% |
| Capital Expenditure | -450.00% | 99.93% | -662.71% | 59.73% | -17.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -450.00% | 99.93% | -662.71% | 59.73% | -17.99% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | 177.07% | 80.59% | -39,791.67% | -300.00% | 0.00% |
| Issuance of Common Stock | -100.00% | -99.99% | 144.83% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -59.41% | -39,400.00% | 99.56% |
| Cash from Financing | 177.09% | -104.93% | 170.13% | 89,912.90% | -100.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.87% | -142.66% | 1,092.22% | 115.78% | -12,105.96% |